Showing results (31-40 of 54) with videos related to
Sort By:
Pageof 6
American Journal of Surgery|June 18, 2017
Do online prognostication tools represent a valid alternative to genomic profiling in the context of adjuvant treatment of early breast cancer? A systematic review of the literatureHiba El Hage Chehade, Umar Wazir, Kinan Mokbel, et al.Cancers|July 14, 2023
Omitting Sentinel Lymph Node Biopsy after Neoadjuvant Systemic Therapy for Clinically Node Negative HER2 Positive and Triple Negative Breast Cancer: A Pooled AnalysisMunaser Alamoodi, Umar Wazir, Kinan Mokbel, et al.Anticancer Research|May 7, 2013
The mRNA expression of inhibitors of DNA binding-1 and -2 is associated with advanced tumour stage and adverse clinical outcome in human breast cancerUmar Wazir, Wen G Jiang, Anup K Sharma, et al.Journal of Clinical Medicine|May 25, 2024
Evaluating Magnetic Seed Localization in Targeted Axillary Dissection for Node-Positive Early Breast Cancer Patients Receiving Neoadjuvant Systemic Therapy: A Comprehensive Review and Pooled AnalysisMunaser Alamoodi, Umar Wazir, Rita A Sakr, et al.Anticancer Research|May 7, 2013
P14ARF is down-regulated during tumour progression and predicts the clinical outcome in human breast cancerUmar Wazir, Wen G Jiang, Hemad Yasaei, et al.Anticancer Research|September 16, 2016
Oncological Safety of Lipofilling in Patients with Breast Cancer: A Meta-analysis and Update on Clinical PracticeUmar Wazir, Hiba El Hage Chehade, Hannah Headon, et al.American Journal of Surgery|October 25, 2016
Is sentinel lymph node biopsy indicated in patients with a diagnosis of ductal carcinoma in situ? A systematic literature review and meta-analysisHiba El Hage Chehade, Hannah Headon, Umar Wazir, et al.Anticancer Research|January 10, 2014
The interaction between DAP1 and autophagy in the context of human carcinogenesisUmar Wazir, Zubair S Khanzada, Wen G Jiang, et al.Cancer Genomics & Proteomics|July 23, 2014
Current state of mTOR targeting in human breast cancerUmar Wazir, Ali Wazir, Zubair S Khanzada, et al.Scientific Reports|February 21, 2020
Locoregional therapy of the primary tumour in de novo stage IV breast cancer in 216 066 patients: A meta-analysisRitika Gera, Hiba E L Hage Chehade, Umar Wazir, et al.Pageof 6